INS and metabolic dysfunction-associated steatotic liver disease: The hepatic insulin resistance derived from NAFLD generally implies the insufficient ability of insulin to suppress glycogenolysis, gluconeogenesis, and glucose output in the liver, thereby causing decreases in glucose disposal, consequently leading to type 2 diabetes (T2DM), and metabolic syndrome [2, 3].